News Focus
News Focus
Post# of 257579
Next 10
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

Re: ghmm post# 76661

Sunday, 04/26/2009 11:04:45 PM

Sunday, April 26, 2009 11:04:45 PM

Post# of 257579
INFORM-1 HCV Trial Design

INFORM-1 tests the combination of ITMN-191 (a protease inhibitor)
and R7128 (a nucleoside polymerase inhibitor) without either
interferon or ribavirin.

Note that two of the three latter cohorts are in the second-line
setting (for null and non-null responders, respectively, during
first-line treatment).

R7227 is an alternate name for ITMN-191.



“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today